Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Lara Pharm's primary focus in the pharmaceutical industry?
- Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology, aiming to mass-produce standardized cannabis-based prescription drugs.
- What specific product has Lara Pharm developed for cannabinoid delivery?
- Lara Pharm has developed an inhaler designed to deliver a controlled dose of cannabinoids.
- When was Lara Pharm founded?
- Lara Pharm was founded in November 2010.
- What was the total amount of funding raised by Lara Pharm?
- Lara Pharm raised a total of $1,500,000 in funding. For a full financing history, please refer to startupim.
- When did Lara Pharm complete its Seed funding round and who was a key investor?
- Lara Pharm completed a Seed funding round in April 2014, with SciSparc listed as an investor.
- When and by whom was Lara Pharm acquired?
- Lara Pharm was acquired by Israeli Therapix Biosciences Ltd. (formerly NasVax) in August 2014.
- What was the acquisition amount for Lara Pharm?
- Lara Pharm was acquired for $2,300,000 in August 2014.
- What is the current status of Lara Pharm?
- Lara Pharm is currently inactive due to its acquisition by SciSparc in August 2014.
- Who is a recognized founder of Lara Pharm?
- Rita Alter is a recognized founder of Lara Pharm.